The nurse, Elet Neilson, faces criminal charges for allegedly diverting drugs and infecting patients with hepatitis C.
State authorities and federal prosecutors say Ms. Neilson exposed patients to hepatitis C at Davis hospital and Ogden, Utah-based McKay-Dee Hospital. In 2015, the hospitals sent letters warning 7,200 former patients of potential hepatitis C exposure.
In the most recent lawsuit, the second patient, Daniel Harger, claims the hospital failed to prevent Ms. Neilson from tampering with patient medication, reusing syringes and exposing patients to disease.
Ms. Neilson administered two doses of morphine to Mr. Harger when he went to the emergency room in 2011, according to the lawsuit.
During unrelated medical treatment in November 2017, Mr. Harger tested positive for hepatitis C virus genotype 2b, which was the same strain linked to Ms. Neilson, according to a 2016 investigation by the Utah Department of Health.
Attorneys for the hospital and Ms. Neilson have separately filed answering documents denying Mr. Harger’s allegations.
More articles on clinical leadership and infection control:
21 hospitalized in 29-state antibiotic-resistant Salmonella outbreak
First pediatric flu death reported in 2018-19 season
6 kids diagnosed with measles in New York
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
